Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Avrobio Inc
(NQ:
AVRO
)
1.400
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Jun 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Avrobio Inc
< Previous
1
2
3
4
5
6
7
Next >
AVROBIO Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 08, 2022
From
AVROBIO, Inc.
Via
Business Wire
AVROBIO to Participate in Four Upcoming Investor Conferences in September
August 31, 2022
From
AVROBIO, Inc.
Via
Business Wire
Recap: Avrobio Q2 Earnings
August 09, 2022
Avrobio (NASDAQ:AVRO) reported its Q2 earnings results on Tuesday, August 9, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
AVROBIO Reports Second Quarter 2022 Financial Results and Provides Business Update
August 09, 2022
From
AVROBIO, Inc.
Via
Business Wire
Avrobio's Pompe Disease Gene Therapy Shows Efficacy, Safety In Preclinical Study
May 18, 2022
Via
Benzinga
AVROBIO Shares Jumps On Encouraging Data From Early-Stage Gene Therapy Study
May 17, 2022
Via
Benzinga
Avrobio: Q1 Earnings Insights
May 10, 2022
Avrobio (NASDAQ:AVRO) reported its Q1 earnings results on Tuesday, May 10, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
AVROBIO Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 04, 2022
From
AVROBIO, Inc.
Via
Business Wire
AVROBIO to Participate in Two Upcoming Investor Conferences in August
August 01, 2022
From
AVROBIO, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
July 29, 2022
Gainers Nanobiotix (NASDAQ:NBTX) shares rose 16.4% to $2.7 during Friday's after-market session. The company's market cap stands at $94.1 million.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
July 13, 2022
Via
Benzinga
Recap: Avrobio Q4 Earnings
March 17, 2022
Avrobio (NASDAQ:AVRO) reported its Q4 earnings results on Thursday, March 17, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings...
Via
Benzinga
AVROBIO Shares Climb As FDA Grants Orphan Drug Status To Genetic Disorder Candidate
July 13, 2022
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation for AVROBIO’s (NASDAQ: AVRO) lead drug AVR-RD-05 for the treatment of mucopolysaccharidosis type II (MPSII), or Hunter...
Via
Benzinga
AVROBIO Receives Orphan Drug Designation from the U.S. Food and Drug Administration for AVR-RD-05, a Gene Therapy for Mucopolysaccharidosis Type II (MPSII) or Hunter Syndrome
July 13, 2022
From
AVROBIO, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
July 07, 2022
Via
Benzinga
AVROBIO Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 06, 2022
From
AVROBIO
Via
Business Wire
12 Health Care Stocks Moving In Thursday's After-Market Session
June 30, 2022
Gainers
Via
Benzinga
AVROBIO Announces Preclinical Gene Therapy Data for Pompe Disease at American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
May 18, 2022
From
AVROBIO, Inc.
Via
Business Wire
AVROBIO Reports Positive Data From Phase 1/2 Clinical Trial of Investigational Gene Therapy for Cystinosis, Including New Interim Data on Neurocognitive Measures
May 17, 2022
From
AVROBIO, Inc.
Via
Business Wire
The Week Ahead In Biotech: Gene & Cell Therapy Conference, Tapering Earnings News, OKYO Pharma IPO And More
May 16, 2022
Biopharma stocks remained largely unchanged in the week ending May 13, with the defensive nature of the sector coming to its aid. Stocks reacted to the broader market move and earnings news from...
Via
Benzinga
AVROBIO to Present at the H.C. Wainwright Global Investment Conference
May 16, 2022
From
AVROBIO, Inc.
Via
Business Wire
AVROBIO Reports First Quarter 2022 Financial Results and Provides Business Update
May 10, 2022
From
AVROBIO
Via
Business Wire
AVROBIO Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 06, 2022
From
AVROBIO, Inc.
Via
Business Wire
AVROBIO to Present New Clinical and Preclinical Data at the ASGCT 25th Annual Meeting
May 03, 2022
From
AVROBIO, Inc.
Via
Business Wire
AVROBIO Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
April 06, 2022
From
AVROBIO, Inc.
Via
Business Wire
AVROBIO to Present at the 21st Annual Needham Virtual Healthcare Conference
April 05, 2022
From
AVROBIO, Inc.
Via
Business Wire
AVROBIO Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides Business Update
March 17, 2022
From
AVROBIO, Inc.
Via
Business Wire
After Fabry Trial Setback, Avrobio Hopes Rebound With Lysosomal Storage Disorder Data
February 09, 2022
Avrobio Inc's (NASDAQ: AVRO) gene therapy for a rare lysosomal storage disorder
Via
Benzinga
The Daily Biotech Pulse: Bristol-Myers Squibb Announces $5B Accelerated Buyback, Qiagen Reaps COVID Testing Windfall, WORLDSymposium Presentations Kick In
February 09, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
February 10, 2022
On Thursday, 89 companies hit new 52-week lows. Noteable 52-Week Lows: The company with the largest market cap to set a new 52-week low was Seagen (NASDAQ:SGEN)....
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.